Bellicum Pharmaceuticals (BLCM) has released an update to notify the public and investors about the unregistered sales of equity securities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
On January 24, 2024, Bellicum Pharmaceuticals, Inc. issued one share of Series A Junior Preferred Stock, known as the Super-Voting Share, to current director Richard A. Fair for $0.01. This private transaction was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as it was not a public offering.
For further insights into BLCM stock, check out TipRanks’ Stock Analysis page.